Merit E. Cudkowicz, Md
Clinical trials sponsored by Merit E. Cudkowicz, Md, explained in plain language.
-
New ALS drug put to the test in major trial
Disease control CompletedThis clinical trial tested an investigational drug called ABBV-CLS-7262 in 310 people with ALS, a progressive nerve disease. The goal was to see if the drug could slow disease progression and improve survival over 24 weeks. Researchers measured changes in physical function and br…
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope in ALS fight: DNL343 drug tested in major trial
Disease control CompletedThis clinical trial tested a drug called DNL343 in 249 people with ALS, a disease that weakens muscles over time. The goal was to see if DNL343 could slow the disease's progress and improve survival. The study used a flexible platform design to test multiple treatments efficientl…
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated May 14, 2026 12:03 UTC